Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Top Trends for Swoon-Worthy Cruise Vacations
-
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual
-
Net Asset Value(s)
-
Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For”
-
Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For”
-
Airia Shortlisted in The 2026 Security Awards
-
North Texas Food Bank Expands Annual Mahjong Fundraiser to Fight Hunger
-
Bioxtreme Announces Strategic Investment Led by Serra Holding and Introduces Plaxtreme to Accelerate Neurorehabilitation Innovation
-
Jayman BUILT Sets a Platinum Benchmark with BUILT GREEN® Certification
-
Writer Christa Couture hits the road for more immersive, accessible Canadian adventures on Season 7 of Postcards From, returning April 29 to AMI-tv and AMI+
-
Just Published! A Young Chef's Journey Featuring an Enchanted Prosthetic and a Culinary Mystery Await Young Readers In New Release
-
Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call
-
QuestionPro Acquires Fathom to Lead in AI-Powered Open-Ended Analysis
-
Posifa Technologies Introduces PGS5100 Series Hydrogen Sensors for EV Battery Safety and Leak Monitoring
-
ENR FutureTech 2026 Announces Top Speaker Lineup for May 4-6 Return to San Francisco
-
AcuityTec Expands Device and Payment Intelligence to Strengthen Fraud Detection Across the Customer Lifecycle
-
Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine
-
Just Published! A Young Chef's Journey Featuring an Enchanted Prosthetic and a Culinary Mystery Await Young Readers In New Release
-
BIC: Annual General Meeting of May 20, 2026 - Availability of the preparatory documents for the General Meeting
-
Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting
-
Gradient Deploys Window Heat Pumps at Providence Public Housing Tower, Unlocking 450,000 kWh in Annual Savings
-
Patriot Mobile joins America First Policy Institute for America’s 250th Celebration in Fort Worth, Texas
-
Alexander’s Announces First Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call
-
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
-
Vaughan’s electricity grid gets $46.2 million boost to support rapid growth
-
SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching
-
SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching
-
Five Seasonal Flooding Safety Tips from TSSA
-
TradeView Releases New Guide on Platform Utility and Market Position
-
Sidetrade Names Two Leaders to Accelerate its AI-native Transformation
-
Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors
-
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
-
NEXT.io Launches New Media Brand, NEXTPredict.io, and Will Host the World’s First Prediction Markets Summit
-
Kitron Secures EUR 37 Million order for Next-Generation Tactical Communication Equipment
-
Vornado Announces First Quarter Earnings Release Date and Conference Call Information
-
UAB “Atsinaujinančios energetikos investicijos” issue of MEUR 2,029,000 of series 1, tranche 3 bonds intended for retail investors
-
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
-
Gifts for Mom Under $25 Expand to Include Fine Jewelry This Mother's Day From Cate & Chloe
-
Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
-
Global Virus Network on Measles Resurgence
-
Gifts for Mom Under $25 Expand to Include Fine Jewelry This Mother's Day From Cate & Chloe
-
Drilling at Swanson Gold Deposit Confirms Large-Scale Gold Discovery with 1.18 g/t Au over 255.04 metres and 1.65 g/t Au over 136.01 metres
-
Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
-
MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution
-
Skyworks Sets Date for Second Quarter Fiscal 2026 Earnings Release and Conference Call
-
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
-
The Ungoverned Workforce: Cybersecurity Insiders Finds 92% Lack Visibility Into AI Identities
-
DocHub Expands PDF Editing Capabilities With The New Edit Text Feature
-
DocHub Expands PDF Editing Capabilities With The New Edit Text Feature
-
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
